León Leticia G, Carballo Rubén M, Vega-Hernández María C, Martín Víctor S, Padrón Juan I, Padrón José M
Instituto Universitario de Bio-Orgánica Antonio González (IUBO-AG), Universidad de La Laguna, C/ Astrofísico Francisco Sánchez 2, 38206 La Laguna, Spain.
Bioorg Med Chem Lett. 2007 May 15;17(10):2681-4. doi: 10.1016/j.bmcl.2007.03.010. Epub 2007 Mar 7.
A series of trans-2-alkyl-4-halopiperidines and 2-alkyl-4-halo-1,2,5,6-tetrahydropyridines were prepared by means of an iron(III) catalyzed process. The in vitro antiproliferative activities were examined in the human solid tumor cell lines A2780 (ovarian cancer), SW1573 (non-small cell lung cancer), and WiDr (colon cancer). The results on the biological activity revealed that, in general, the 2-alkyl-4-halo-1,2,5,6-tetrahydropyridine analogs are more potent than the trans-2-alkyl-4-halopiperidine derivatives. A remarkable selectivity of the aza compound 5f for the resistant cell line WiDr was observed. Cell cycle studies revealed a G(2)/M phase arrest for 5f.
通过铁(III)催化过程制备了一系列反式-2-烷基-4-卤代哌啶和2-烷基-4-卤代-1,2,5,6-四氢吡啶。在人实体瘤细胞系A2780(卵巢癌)、SW1573(非小细胞肺癌)和WiDr(结肠癌)中检测了其体外抗增殖活性。生物活性结果表明,一般而言,2-烷基-4-卤代-1,2,5,6-四氢吡啶类似物比反式-2-烷基-4-卤代哌啶衍生物更具活性。观察到氮杂化合物5f对耐药细胞系WiDr具有显著的选择性。细胞周期研究显示5f导致G(2)/M期阻滞。